Scientists Behind AstraZeneca COVID Jab Rush to Develop Plague Vaccine as Pandemic Fears Grow
An article questions the development of a plague vaccine by the Oxford team behind the AstraZeneca COVID-19 shot, citing concerns over the vaccine platform's safety. It argues that the trial size is insufficient and that existing treatments are effective.
Why it matters
The piece reflects growing skepticism and public concern regarding vaccine development platforms and pharmaceutical transparency.
With the Russian plague scare all over the internet, new focus and questions are being asked about the Oxford team that made the AstraZeneca COVID shot and why they’ve developed a Black Death vaccine, and why British military scientists want the UK to stockpile it.
This plague vaccine is built on the same platform as the AstraZeneca COVID shot, which was pulled worldwide in 2024 after the company admitted in court it can cause rare but dangerous blood clots. Now the same people want governments to stockpile a plague version, based on a trial that’s far too small to catch that kind of problem. And plague is a disease that cheap antibiotics already cure when they’re given early.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in